Ginkgo Bioworks falls on downbeat 2025 forecast

Ginkgo Bioworks Holdings

26/02/2025 16:31

** Shares of biotech co Ginkgo Bioworks DNA.N fall 4% to $9.9

** Co late on Tuesday forecast 2025 revenue to be $160 mln to $180 mln, lower than analyst estimates of $189 mln as per data compiled by LSEG

** DNA reported Q4 net loss of $107.5 mln, vs analyst estimates of $80.1 mln

** Co reported Q4 revenue of $44 mln, vs analyst estimates of $44.5 mln

** Stock has fallen 82.4% in the past 12 months

 (Reporting by Padmanabhan Ananthan)

 ((Padmanabhan.Ananthan@thomsonreuters.com;))